High producing cell lines and efficient workflows are essential to any cell line development platform. As a global CDMO, AGC Biologics strives for continuous innovation in our CLD platform. Our company is committed to producing top quality of clonal cell lines for our development and manufacturing services for protein-based biologics and advanced therapies. Implementation of the Solentim ICON by Advanced Instruments into our CLD workflow has allowed us to significantly decrease our timelines while increasing our high throughput screening methods to pinpoint the top producing clones. Seamless integration of the ICON into our CLD workflows has allowed AGC to rapidly advance our mAb platform to a higher level of productivity than previous methods.